| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:49 UTC |
|---|
| Update Date | 2020-02-26 21:39:20 UTC |
|---|
| HMDB ID | HMDB0014008 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Hydroxylansoprazole |
|---|
| Description | Hydroxylansoprazole is only found in individuals that have used or taken Lansoprazole. Hydroxylansoprazole is a metabolite of Lansoprazole. Hydroxylansoprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety. |
|---|
| Structure | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1 InChI=1S/C16H14F3N3O3S/c1-9-13(20-5-4-14(9)25-8-16(17,18)19)7-26(24)15-21-11-3-2-10(23)6-12(11)22-15/h2-6,23H,7-8H2,1H3,(H,21,22) |
|---|
| Synonyms | | Value | Source |
|---|
| 5-Hydroxy lansoprazole | HMDB | | 2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulphinyl}-1H-1,3-benzodiazol-6-ol | Generator | | 5-Hydroxylansoprazole | MeSH |
|
|---|
| Chemical Formula | C16H14F3N3O3S |
|---|
| Average Molecular Weight | 385.361 |
|---|
| Monoisotopic Molecular Weight | 385.070796634 |
|---|
| IUPAC Name | 2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazol-5-ol |
|---|
| Traditional Name | 2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazol-5-ol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1 |
|---|
| InChI Identifier | InChI=1S/C16H14F3N3O3S/c1-9-13(20-5-4-14(9)25-8-16(17,18)19)7-26(24)15-21-11-3-2-10(23)6-12(11)22-15/h2-6,23H,7-8H2,1H3,(H,21,22) |
|---|
| InChI Key | IDCLTMRSSAXUNY-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzimidazoles |
|---|
| Sub Class | Sulfinylbenzimidazoles |
|---|
| Direct Parent | Sulfinylbenzimidazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Sulfinylbenzimidazole
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Methylpyridine
- Pyridine
- Benzenoid
- Azole
- Imidazole
- Heteroaromatic compound
- Sulfoxide
- Azacycle
- Sulfinyl compound
- Ether
- Hydrocarbon derivative
- Organic oxygen compound
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Alkyl fluoride
- Organopnictogen compound
- Organic nitrogen compound
- Organic oxide
- Alkyl halide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.48 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9452 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.79 minutes | 32390414 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Hydroxylansoprazole,1TMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C)=CC=C2[NH]1 | 2775.5 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,1TMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C)=CC=C2[NH]1 | 2775.5 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,1TMS,isomer #2 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1[Si](C)(C)C | 2797.6 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,1TMS,isomer #2 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1[Si](C)(C)C | 2797.6 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,2TMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C)=CC=C2N1[Si](C)(C)C | 2869.2 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,2TMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C)=CC=C2N1[Si](C)(C)C | 2879.0 | Standard non polar | 33892256 | | Hydroxylansoprazole,2TMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C)=CC=C2N1[Si](C)(C)C | 3055.6 | Standard polar | 33892256 | | Hydroxylansoprazole,1TBDMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2[NH]1 | 2990.8 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,1TBDMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2[NH]1 | 2990.8 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,1TBDMS,isomer #2 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1[Si](C)(C)C(C)(C)C | 2982.8 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,1TBDMS,isomer #2 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1[Si](C)(C)C(C)(C)C | 2982.8 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,2TBDMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2N1[Si](C)(C)C(C)(C)C | 3224.4 | Semi standard non polar | 33892256 | | Hydroxylansoprazole,2TBDMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2N1[Si](C)(C)C(C)(C)C | 3297.9 | Standard non polar | 33892256 | | Hydroxylansoprazole,2TBDMS,isomer #1 | CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2N1[Si](C)(C)C(C)(C)C | 3222.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylansoprazole GC-MS (Non-derivatized) - 70eV, Positive | splash10-0zfr-2952000000-c1de0f80b7a0e73b5ad9 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylansoprazole GC-MS (1 TMS) - 70eV, Positive | splash10-0fk9-7963100000-726d2b7e23c53b6e84a6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylansoprazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylansoprazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylansoprazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 10V, Positive-QTOF | splash10-0f79-0179000000-57328872e170f2261542 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 20V, Positive-QTOF | splash10-0udi-0392000000-925983493708ce1067b5 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 40V, Positive-QTOF | splash10-0ab9-2920000000-2d205162a10bc75f2aaa | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 10V, Negative-QTOF | splash10-001i-0709000000-f57a02254b707c6cce15 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 20V, Negative-QTOF | splash10-001i-0900000000-c639fd83f9c81f927ce3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 40V, Negative-QTOF | splash10-001i-2901000000-12d09e44e8f064494ad2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 10V, Negative-QTOF | splash10-001i-0906000000-a79e56e899f2add7eb6a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 20V, Negative-QTOF | splash10-001i-2931000000-d84e6ebfe0e7aa43deae | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 40V, Negative-QTOF | splash10-00e9-2960000000-5f593d75434ba4b829c0 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 10V, Positive-QTOF | splash10-000i-0039000000-0550354b42a9f993385a | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 20V, Positive-QTOF | splash10-0uei-0392000000-9a67432c271977b4662c | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylansoprazole 40V, Positive-QTOF | splash10-0080-0950000000-bd5b977284c693b801ea | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|